AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30398862 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro assessment of melanin binding properties of small molecules
Number of subjects: 3400
Study 30398862 — intervention group
Group type: EXPERIMENTAL
Intervention: In silico model predicting melanin binding
Number of subjects: 3400
Study 30398862 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlations between melanin binding and molecular properties
Number of subjects: 3400
Study 27317305 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 150 mg
Number of subjects: 12
Study 27317305 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 300 mg
Number of subjects: 12
Study 27317305 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 600 mg
Number of subjects: 12
Study 27317305 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple dose of peramivir 600 mg
Number of subjects: 12
Study 24285801 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation programme (supervised training and home exercises)
Number of subjects: 69
Study 24285801 — intervention group
Group type: COMPARATOR
Intervention: Educational-behavioural programme
Number of subjects: 69
Study 24285801 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study 22424799 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (METH)
Number of subjects: 82
Study 22424799 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 82
Study 22424799 — intervention group
Group type: COMPARATOR
Intervention: Control (drug-free)
Number of subjects: 82
Study 22424799 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (METH) and Buprenorphine (BUP)
Number of subjects: 82
Study 20384415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential name‐face matching task with famous faces
Number of subjects: 0
Study 20384415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential name‐face matching task with nonfamous faces
Number of subjects: 0
Study 20384415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential face-name matching task with names
Number of subjects: 0
Study 18025064 — intervention group
Group type: EXPERIMENTAL
Intervention: Net Present Value risk communication intervention
Number of subjects: 100
Study 18025064 — intervention group
Group type: COMPARATOR
Intervention: Future Value risk communication intervention (Control)
Number of subjects: 100
Study 16112972 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study 16112972 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 0
Study 12005458 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding (started on day 1)
Number of subjects: 150
Study 12005458 — intervention group
Group type: COMPARATOR
Intervention: Late enteral feeding (started on day 5, with 20% of estimated daily requirements during the first 4 days)
Number of subjects: 150
Study 10424513 — intervention group
Group type: EXPERIMENTAL
Intervention: IV levofloxacin, 500 mg qd for 7 days
Number of subjects: 12
Study 10424513 — intervention group
Group type: EXPERIMENTAL
Intervention: IV alatrofloxacin, 200 mg qd for 7 days
Number of subjects: 12
Study 7584749 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compressions with audible tone guidance
Number of subjects: 12
Study 7584749 — intervention group
Group type: COMPARATOR
Intervention: Chest compressions without audible tone guidance
Number of subjects: 12
Study 2207399 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 25 mg/kg over three days
Number of subjects: 263
Study 2207399 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine 75 mg and sulfadoxine 1500 mg as a single dose
Number of subjects: 263
Study 2207399 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil 1.2 mg/kg and dapsone 2.4 mg/kg as a single dose
Number of subjects: 263
Study 6993445 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylpropion hydrochloride
Number of subjects: 60
Study 6993445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30633917 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular vaginal assessments (4-hourly prior to each oral misoprostol dose)
Number of subjects: 204
Study 30633917 — intervention group
Group type: COMPARATOR
Intervention: Restricted vaginal assessments (only if indicated)
Number of subjects: 204
Study 30633917 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular vaginal assessments
Number of subjects: 204
Study 30633917 — intervention group
Group type: COMPARATOR
Intervention: Restricted vaginal assessments
Number of subjects: 204
Study 28432578 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise intervention (6-month culturally congruent adherence counseling)
Number of subjects: 215
Study 28432578 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 215
Study 24259197 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention
Number of subjects: 664
Study 23504383 — intervention group
Group type: EXPERIMENTAL
Intervention: adalimumab 40 mg every other week for 24 weeks
Number of subjects: 136
Study 23504383 — intervention group
Group type: COMPARATOR
Intervention: placebo every other week for 24 weeks
Number of subjects: 136
Study 21642927 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Education Pulmonary Rehabilitation Programme (SEPRP)
Number of subjects: 0
Study 21642927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses working in primary care
Number of subjects: 0
Study 19546510 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser treatment
Number of subjects: 325
Study 16990120 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour online training program for workplace violence (WPV)
Number of subjects: 43
Study 15247354 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin alone (30 mg/m² every three weeks for 10 doses)
Number of subjects: 206
Study 15247354 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrazoxane (300 mg/m²) followed by doxorubicin
Number of subjects: 206
Study 15247354 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (doxorubicin alone and dexrazoxane + doxorubicin)
Number of subjects: 206
Study 11770708 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose pravastatin (5 mg/day)
Number of subjects: 665
Study 11770708 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose pravastatin (10-20 mg/day)
Number of subjects: 665
Study 9037443 — intervention group
Group type: EXPERIMENTAL
Intervention: Test DPI (Easyhaler)
Number of subjects: 25
Study 9037443 — intervention group
Group type: COMPARATOR
Intervention: Reference DPI
Number of subjects: 25
Study 9037443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DPIs
Number of subjects: 25
Study 11830951 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy applied during and following third molar removal
Number of subjects: 0
Study 11830951 — intervention group
Group type: COMPARATOR
Intervention: No active additional laser treatment (placebo)
Number of subjects: 0
Study 2737688 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (PROP)
Number of subjects: 0
Study 2737688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (NIF)
Number of subjects: 0
Study 2737688 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT)
Number of subjects: 0
Study 30902043 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial flow reserve (MFR) measured with 82Rb-PET/CT
Number of subjects: 151
Study 30902043 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary vascular resistance during stress
Number of subjects: 151
Study 25913062 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz transcranial alternating current stimulation (10Hz-tACS) of the frontal cortex
Number of subjects: 20
Study 25913062 — intervention group
Group type: COMPARATOR
Intervention: 40Hz transcranial alternating current stimulation (40Hz-tACS) of the frontal cortex
Number of subjects: 20
Study 23886027 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 1200 mg/day + risperidone
Number of subjects: 40
Study 23886027 — intervention group
Group type: COMPARATOR
Intervention: Placebo + risperidone
Number of subjects: 40
Study 23886027 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) + risperidone
Number of subjects: 40
Study 21087377 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) combined with lamivudine and efavirenz or nevirapine
Number of subjects: 151
Study 21087377 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV) combined with lamivudine and efavirenz or nevirapine
Number of subjects: 151
Study 21087377 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (ddI)
Number of subjects: 151
Study 21087377 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 151
Study 19139252 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience Corps (EC)
Number of subjects: 149
Study 19139252 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 149
Study 16800986 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanlijian (KLJ) combined with conventional therapy
Number of subjects: 60
Study 16800986 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 60
Study 12862327 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva maneuver at 40 mmHg expiratory pressure for 15 seconds
Number of subjects: 33
Study 12862327 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders (n = 20)
Number of subjects: 33
Study 12862327 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 33
Study 10759275 — intervention group
Group type: EXPERIMENTAL
Intervention: National guidelines adapted to local protocols
Number of subjects: 946
Study 8798135 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0
Study 8798135 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stent technology
Number of subjects: 0
Study 8798135 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive carotid interventions
Number of subjects: 0
Study 1875441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid and alpha‐tocopherol
Number of subjects: 46
Study 1875441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 46
Study 1875441 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha‐tocopherol
Number of subjects: 46
Study 1875441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 7051762 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 6
Study 7051762 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 6
Study 7051762 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 6
Study 7051762 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprenolol and Metoprolol
Number of subjects: 6
Study 31928920 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) granules based on syndrome differentiation (Bao‐fei Hua‐xian granule, Jin‐shui Huan‐xian granule, Yang‐qing Kang‐xian granule)
Number of subjects: 80
Study 31928920 — intervention group
Group type: COMPARATOR
Intervention: Placebo TCM granules
Number of subjects: 80
Study 30604204 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised walking program (3 times a week for 16 weeks)
Number of subjects: 45
Study 29051138 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-guided Ambulant Activity Feedback (AAF) therapy (n=62)
Number of subjects: 167
Study 29051138 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologist-guided Web-based mindfulness-based cognitive therapy (eMBCT; n=55)
Number of subjects: 167
Study 29051138 — intervention group
Group type: COMPARATOR
Intervention: Unguided active control condition receiving psycho-educational emails (n=50)
Number of subjects: 167
Study 27468664 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking relapse-prevention intervention (SRP) group: standard of care plus 8 relapse-prevention booklets mailed over a 3-month period and a targeted educational DVD developed specifically for cancer patients.
Number of subjects: 414
Study 27468664 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group: received the institution's standard of care.
Number of subjects: 414
Study 24327135 — intervention group
Group type: EXPERIMENTAL
Intervention: Family instrumental support
Number of subjects: 1422
Study 24327135 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline family instrumental support
Number of subjects: 1422
Study 24327135 — intervention group
Group type: COMPARATOR
Intervention: Emotional support from family or peers
Number of subjects: 1422
Study 22728693 — intervention group
Group type: EXPERIMENTAL
Intervention: Single MRI slice 5-10 cm above L(4)-L(5)
Number of subjects: 123
Study 22728693 — intervention group
Group type: EXPERIMENTAL
Intervention: Single MRI slice L(4)-L(5)
Number of subjects: 123
Study 22728693 — intervention group
Group type: EXPERIMENTAL
Intervention: Single MRI slice
Number of subjects: 123
Study 22728693 — intervention group
Group type: EXPERIMENTAL
Intervention: Multislice imaging
Number of subjects: 123
Study 19846026 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir
Number of subjects: 0
Study 19846026 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 0
Study 17561998 — intervention group
Group type: COMPARATOR
Intervention: Vehicle instillation (100 ml of 10% ethanol in saline)
Number of subjects: 23
Study 17561998 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX instillation (100 ml of 50 nM RTX in 10% ethanol in saline)
Number of subjects: 23
Study 15447895 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (3.0 g/d; 50:50 blend of cis-9,trans-11 CLA and trans-10,cis-12 CLA)
Number of subjects: 32
Study 15447895 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation
Number of subjects: 32
Study 11451718 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (wheat gluten)
Number of subjects: 20
Study 11451718 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 20
Study 9742535 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile block plus diclofenac suppository (Group 2)
Number of subjects: 61
Study 9742535 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac suppository alone (Group 3)
Number of subjects: 61
Study 9742535 — intervention group
Group type: COMPARATOR
Intervention: Penile block (Group 1)
Number of subjects: 61
Study 7724748 — intervention group
Group type: EXPERIMENTAL
Intervention: CT imaging
Number of subjects: 189
Study 7724748 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 189
Study 7724748 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient‐echo and T1‐weighted spin‐echo sequences
Number of subjects: 189
Study 7724748 — intervention group
Group type: EXPERIMENTAL
Intervention: T1‐weighted spin‐echo sequences
Number of subjects: 189
Study 7724748 — intervention group
Group type: EXPERIMENTAL
Intervention: T2‐weighted spin‐echo sequences
Number of subjects: 189
Study 2643284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (n = 57)
Number of subjects: 89
Study 2643284 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 32)
Number of subjects: 89
Study 2643284 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 89
Study 2643284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 1089363 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan alone
Number of subjects: 12
Study 1089363 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan combined with L-dopa
Number of subjects: 12
Study 1089363 — intervention group
Group type: COMPARATOR
Intervention: L-dopa combined with L-tryptophan
Number of subjects: 12
Study 31952931 — intervention group
Group type: EXPERIMENTAL
Intervention: NC+AC group (phosphoric acid, sodium hypochlorite, and sulfinic acid sodium salt)
Number of subjects: 36
Study 31952931 — intervention group
Group type: EXPERIMENTAL
Intervention: NC group (phosphoric acid and sodium hypochlorite)
Number of subjects: 36
Study 31952931 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 36
Study 30898897 — intervention group
Group type: EXPERIMENTAL
Intervention: Brock model (original)
Number of subjects: 7879
Study 30898897 — intervention group
Group type: EXPERIMENTAL
Intervention: Brock model (updated after recalibration)
Number of subjects: 7879
Study 30898897 — intervention group
Group type: EXPERIMENTAL
Intervention: New covariates (including pack-year history)
Number of subjects: 7879
Study 28488449 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized medication training (20 min)
Number of subjects: 104
Study 28488449 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without training
Number of subjects: 104
Study 26050238 — intervention group
Group type: EXPERIMENTAL
Intervention: Yale Pharyngeal Residue Severity Rating Scale
Number of subjects: 261
Study 23993258 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid revascularization (carotid endarterectomy or stenting)
Number of subjects: 89
Study 23993258 — intervention group
Group type: EXPERIMENTAL
Intervention: No-to-mild WML
Number of subjects: 89
Study 23993258 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate WML
Number of subjects: 89
Study 23993258 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe WML
Number of subjects: 89
Study 21269454 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for silent ischemia using a bicycle exercise test or Dipyridamole Single Photon Emission Computed Tomography (N = 316)
Number of subjects: 631
Study 21269454 — intervention group
Group type: COMPARATOR
Intervention: Follow-up without screening (usual care) (N = 315)
Number of subjects: 631
Study 21269454 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of DYNAMIT and DIAD results
Number of subjects: 631
Study 19692788 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality therapy (30 mins per session, in addition to conventional therapy)
Number of subjects: 24
Study 19692788 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (40 mins a day, 4 days a week for 4 weeks)
Number of subjects: 24
Study 16369817 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 91
Study 16369817 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 91
Study 16369817 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (for low responders to endurance training)
Number of subjects: 91
Study 16369817 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=18)
Number of subjects: 91
Study 15015820 — intervention group
Group type: EXPERIMENTAL
Intervention: Euphyllin Retard 350 mg under fasting condition
Number of subjects: 10
Study 15015820 — intervention group
Group type: COMPARATOR
Intervention: Euphyllin Retard 350 mg with breakfast
Number of subjects: 10
Study 11168211 — intervention group
Group type: EXPERIMENTAL
Intervention: Astra-Tech (A) system - self-tapping TiO2-blasted screw-shaped implants made of commercially pure titanium
Number of subjects: 0
Study 11168211 — intervention group
Group type: COMPARATOR
Intervention: Brånemark (B) system - self-tapping Mark II implants with machined surface irregularities
Number of subjects: 0
Study 11168211 — intervention group
Group type: EXPERIMENTAL
Intervention: Astra-Tech (A) system
Number of subjects: 0
Study 11168211 — intervention group
Group type: COMPARATOR
Intervention: Brånemark (B) system
Number of subjects: 0
Study 9504133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal breathing
Number of subjects: 8
Study 9504133 — intervention group
Group type: COMPARATOR
Intervention: Oral breathing
Number of subjects: 8
Study 9504133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal breathing at 60 W
Number of subjects: 8
Study 9504133 — intervention group
Group type: COMPARATOR
Intervention: Oral breathing at 60 W
Number of subjects: 8
Study 9504133 — intervention group
Group type: EXPERIMENTAL
Intervention: Both breathing methods at unloaded exercise
Number of subjects: 8
Study 8439713 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine/proliferant injections
Number of subjects: 79
Study 8439713 — intervention group
Group type: COMPARATOR
Intervention: Xylocaine/saline solution injections
Number of subjects: 79
Study 8439713 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study 3516606 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop intraperitoneal insulin infusion
Number of subjects: 8
Study 3516606 — intervention group
Group type: COMPARATOR
Intervention: Intravenous insulin infusion
Number of subjects: 8
Study 31786338 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 69
Study 31786338 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Band (RB) exercise
Number of subjects: 69
Study 31786338 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 69
Study 31786338 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 69
Study 31786338 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP levels
Number of subjects: 69
Study 29450468 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI plus cetuximab
Number of subjects: 143
Study 29450468 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 143
Study 27779946 — intervention group
Group type: EXPERIMENTAL
Intervention: Active processing condition
Number of subjects: 50
Study 27779946 — intervention group
Group type: COMPARATOR
Intervention: Passive processing condition
Number of subjects: 50
Study 24368727 — intervention group
Group type: EXPERIMENTAL
Intervention: NAP/ESO
Number of subjects: 2317
Study 22219470 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally thoracoscopic closure on perfused beating hearts
Number of subjects: 24
Study 22219470 — intervention group
Group type: COMPARATOR
Intervention: Totally thoracoscopic closure on cardioplegic arrested hearts
Number of subjects: 24
Study 22219470 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 20305865 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic metronidazole plus amoxicillin (AP+AB)
Number of subjects: 97